Lake Street Advisors Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Lake Street Advisors Group, LLC
- $2.12 Billion
- Q4 2024
A detailed history of Lake Street Advisors Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Lake Street Advisors Group, LLC holds 779 shares of REGN stock, worth $555,621. This represents 0.03% of its overall portfolio holdings.
Number of Shares
779
Previous 713
9.26%
Holding current value
$555,621
Previous $749,000
26.03%
% of portfolio
0.03%
Previous 0.04%
Shares
11 transactions
Others Institutions Holding REGN
# of Institutions
1,487Shares Held
85.7MCall Options Held
1.53MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.62 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.02 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$5.04 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.45 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.38 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $76.5B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...